Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11979 | 940 | 46.0 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
11979 | 1 | TELMISARTAN//AZILSARTAN//AZILSARTAN MEDOXOMIL | 940 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TELMISARTAN | authKW | 867996 | 14% | 20% | 136 |
2 | AZILSARTAN | authKW | 361048 | 2% | 65% | 17 |
3 | AZILSARTAN MEDOXOMIL | authKW | 361048 | 2% | 65% | 17 |
4 | WERPUNKT NEPHROL HYPERTENSIOL | address | 129932 | 0% | 100% | 4 |
5 | CLIN TRIAL MANAGEMENTITABASHI KU | address | 97449 | 0% | 100% | 3 |
6 | MED SCI CONSULTANCY | address | 97449 | 0% | 100% | 3 |
7 | RENIN ANGIOTENSIN SYSTEM | authKW | 82625 | 10% | 3% | 98 |
8 | ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER | authKW | 78563 | 2% | 16% | 15 |
9 | ANGIOTENSIN RECEPTOR BLOCKER | authKW | 77025 | 5% | 5% | 50 |
10 | TAK 491 | authKW | 73085 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 6904 | 25% | 0% | 239 |
2 | Endocrinology & Metabolism | 4939 | 28% | 0% | 267 |
3 | Pharmacology & Pharmacy | 653 | 17% | 0% | 164 |
4 | Physiology | 474 | 9% | 0% | 81 |
5 | Cardiac & Cardiovascular System | 387 | 9% | 0% | 86 |
6 | Nutrition & Dietetics | 249 | 5% | 0% | 46 |
7 | Medicine, Research & Experimental | 186 | 6% | 0% | 60 |
8 | Medicine, General & Internal | 40 | 5% | 0% | 45 |
9 | Urology & Nephrology | 27 | 2% | 0% | 22 |
10 | Cell Biology | 15 | 4% | 0% | 40 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | WERPUNKT NEPHROL HYPERTENSIOL | 129932 | 0% | 100% | 4 |
2 | CLIN TRIAL MANAGEMENTITABASHI KU | 97449 | 0% | 100% | 3 |
3 | MED SCI CONSULTANCY | 97449 | 0% | 100% | 3 |
4 | MOL CARDIOVASC BIOL PHARMACOL | 72337 | 2% | 15% | 15 |
5 | FRANZ VOLHARD CLIN CHARITE | 64966 | 0% | 100% | 2 |
6 | OBES EDUC INITIAT | 62461 | 1% | 38% | 5 |
7 | GENOM EPIDEMIOL CLIN TRIALSITABASHI KU | 48721 | 0% | 50% | 3 |
8 | BIOL DEV TISSU ADIPEUXCNRSUMR 6543 | 43309 | 0% | 67% | 2 |
9 | CNRS 6543 | 43309 | 0% | 67% | 2 |
10 | PHARMACOLITABASHI KU | 43309 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HYPERTENSION RESEARCH | 17916 | 4% | 1% | 37 |
2 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 10659 | 2% | 2% | 17 |
3 | CARDIOVASCULAR DIABETOLOGY | 7568 | 2% | 1% | 17 |
4 | HYPERTENSION | 5430 | 5% | 0% | 44 |
5 | JOURNAL OF CLINICAL HYPERTENSION | 4232 | 1% | 1% | 12 |
6 | JOURNAL OF HYPERTENSION | 3401 | 3% | 0% | 32 |
7 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 3091 | 3% | 0% | 25 |
8 | AMERICAN JOURNAL OF HYPERTENSION | 2880 | 2% | 0% | 23 |
9 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 2331 | 1% | 1% | 12 |
10 | CURRENT HYPERTENSION REPORTS | 1977 | 1% | 1% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KALUPAHANA, NS , MOUSTAID-MOUSSA, N , (2012) THE RENIN-ANGIOTENSIN SYSTEM: A LINK BETWEEN OBESITY, INFLAMMATION AND INSULIN RESISTANCE.OBESITY REVIEWS. VOL. 13. ISSUE 2. P. 136 -149 | 75 | 57% | 67 |
2 | KALUPAHANA, NS , MOUSTAID-MOUSSA, N , (2012) THE ADIPOSE TISSUE RENIN-ANGIOTENSIN SYSTEM AND METABOLIC DISORDERS: A REVIEW OF MOLECULAR MECHANISMS.CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 47. ISSUE 4. P. 379 -390 | 66 | 62% | 20 |
3 | MARCUS, Y , SHEFER, G , STERN, N , (2013) ADIPOSE TISSUE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) AND PROGRESSION OF INSULIN RESISTANCE.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 378. ISSUE 1-2. P. 1-14 | 83 | 48% | 13 |
4 | DE KLOET, AD , KRAUSE, EG , WOODS, SC , (2010) THE RENIN ANGIOTENSIN SYSTEM AND THE METABOLIC SYNDROME.PHYSIOLOGY & BEHAVIOR. VOL. 100. ISSUE 5. P. 525-534 | 74 | 52% | 65 |
5 | FRIGOLET, ME , TORRES, N , TOVAR, AR , (2013) THE RENIN-ANGIOTENSIN SYSTEM IN ADIPOSE TISSUE AND ITS METABOLIC CONSEQUENCES DURING OBESITY.JOURNAL OF NUTRITIONAL BIOCHEMISTRY. VOL. 24. ISSUE 12. P. 2003-2015 | 83 | 39% | 24 |
6 | FAVRE, GA , ESNAULT, VLM , VAN OBBERGHEN, E , (2015) MODULATION OF GLUCOSE METABOLISM BY THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 308. ISSUE 6. P. E435 -E449 | 68 | 36% | 9 |
7 | PUTNAM, K , SHOEMAKER, R , YIANNIKOURIS, F , CASSIS, LA , (2012) THE RENIN-ANGIOTENSIN SYSTEM: A TARGET OF AND CONTRIBUTOR TO DYSLIPIDEMIAS, ALTERED GLUCOSE HOMEOSTASIS, AND HYPERTENSION OF THE METABOLIC SYNDROME.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 302. ISSUE 6. P. H1219-H1230 | 52 | 44% | 76 |
8 | VAN DER ZIJL, NJ , MOORS, CCM , GOOSSENS, GH , BLAAK, EE , DIAMANT, M , (2012) DOES INTERFERENCE WITH THE RENIN-ANGIOTENSIN SYSTEM PROTECT AGAINST DIABETES? EVIDENCE AND MECHANISMS.DIABETES OBESITY & METABOLISM. VOL. 14. ISSUE 7. P. 586-595 | 58 | 48% | 16 |
9 | PUTNAM, K , BATIFOULIER-YIANNIKOURIS, F , BHARADWAJ, KG , LEWIS, E , KAROUNOS, M , DAUGHERTY, A , CASSIS, LA , (2012) DEFICIENCY OF ANGIOTENSIN TYPE 1A RECEPTORS IN ADIPOCYTES REDUCES DIFFERENTIATION AND PROMOTES HYPERTROPHY OF ADIPOCYTES IN LEAN MICE.ENDOCRINOLOGY. VOL. 153. ISSUE 10. P. 4677-4686 | 32 | 89% | 7 |
10 | MULLER-FIELITZ, H , LANDOLT, J , HEIDBREDER, M , WERTH, S , VOGT, FM , JOHREN, O , RAASCH, W , (2012) IMPROVED INSULIN SENSITIVITY AFTER LONG-TERM TREATMENT WITH AT(1) BLOCKERS IS NOT ASSOCIATED WITH PPAR GAMMA TARGET GENE REGULATION.ENDOCRINOLOGY. VOL. 153. ISSUE 3. P. 1103-1115 | 44 | 64% | 7 |
Classes with closest relation at Level 1 |